Matrix metalloproteinase-3 as a marker of subclinical activity in rheumatoid arthritis patients: Relation to ultrasonographic activity

Sayah, 2005, Rheumatoid arthritis: a review of the cutaneous manifestations, J Am Acad Dermatol, 53, 191, 10.1016/j.jaad.2004.07.023 Osipova, 2020, Rheumatoid arthritis: more than a joint disease, Ned Tijdschr Geneeskd, 164, D4166 Burmester, 2017, Novel treatment strategies in rheumatoid arthritis, Lancet, 389, 2338, 10.1016/S0140-6736(17)31491-5 Prince, 2012, Sustained rheumatoid arthritis remission is uncommon in clinical practice, Arthritis Res Ther, 14, R68, 10.1186/ar3785 Ogishima, 2014, Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis, Mod Rheumatol, 24, 60, 10.3109/14397595.2013.854050 Tagliafico, 2020, Musculoskeletal ultrasound, 81 Hurnakova, 2016, Serum Calprotectin Discriminates subclinical disease activity from ultrasound-defined remission in patients with rheumatoid arthritis in clinical remission, PLoS ONE, 11, e0165498, 10.1371/journal.pone.0165498 Padovano, 2016, Prevalence of ultrasound synovial inflammatory findings in healthy subjects, Ann Rheum Dis, 75, 1819, 10.1136/annrheumdis-2015-208103 Filippucci, 2019, Ultrasound imaging in rheumatoid arthritis, Radiol Med, 124, 1087, 10.1007/s11547-019-01002-2 Burrage, 2006, Matrix metalloproteinases: role in arthritis, Front Biosci, 11, 529, 10.2741/1817 Hattori, 2018, Steroid therapy and renal dysfunction are independently associated with serum levels of matrix metalloproteinase-3 in patients with rheumatoid arthritis, Mod Rheumatol, 28, 242, 10.1080/14397595.2017.1354431 Gheita, 2015, Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage, Acta Reumatol Port, 40, 145 Fadda, 2016, Serum matrix metalloproteinase-3 in rheumatoid arthritis patients: Correlation with disease activity and joint destruction, Egyptian Rheumatol, 38, 153, 10.1016/j.ejr.2016.01.001 Celik, 2021, Upregulation of microRNA-93-5p/microRNA-4668-5p, and promoter methylation of matrix metalloproteinase-3 and interleukin-16 genes in Turkish patients with rheumatoid arthritis, Egyptian Rheumatol, 43, 35, 10.1016/j.ejr.2020.06.004 Sugiyama, 2007, Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis, Clin Calcium, 17, 528 Lerner, 2018, MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis, Best Pract Res Clin Rheumatol, 32, 550, 10.1016/j.berh.2019.01.006 Aletaha, 2010, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Backhaus, 2013, The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy, Ann Rheum Dis, 72, 1163, 10.1136/annrheumdis-2012-201397 Ramírez, 2014, Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers, Arthritis Res Ther, 16, R5, 10.1186/ar4431 Sapundzhieva, 2018, Musculoskeletal ultrasound for predicting remission in patients with rheumatoid arthritis: results from a 1-year prospective study, Rheumatol Int, 38, 1891, 10.1007/s00296-018-4131-0 Nakabo, 2021, Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: a cross-sectional study of rheumatoid arthritis patients, Mod Rheumatol, 31, 334, 10.1080/14397595.2020.1751922 Dejaco, 2012, Ultrasound-defined remission and active disease in rheumatoid arthritis: association with clinical and serologic parameters, Semin Arthritis Rheum, 41, 761, 10.1016/j.semarthrit.2011.09.005 Smyrnova, 2014, The relationship between hemoglobin level and disease activity in patients with rheumatoid arthritis, Rev Bras Reumatol, 54, 437, 10.1016/j.rbr.2014.06.002 Chen, 2020, Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis, Clin Rheumatol, 39, 1737, 10.1007/s10067-019-04873-y Padjen, 2017, Clinical meaning and implications of serum hemoglobin levels in patients with rheumatoid arthritis, Semin Arthritis Rheum, 47, 193, 10.1016/j.semarthrit.2017.03.001 Sun, 2019, Expression of T follicular helper lymphocytes with different subsets and analysis of serum IL-6, IL-17, TGF-β and MMP-3 contents in patients with rheumatoid arthritis, Eur Rev Med Pharmacol Sci, 23, 61 Tuncer, 2019, Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis, Adv Clin Exp Med, 28, 665, 10.17219/acem/94065 Zhou, 2017, Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis, Arthritis Res Ther, 19, 250, 10.1186/s13075-017-1449-z Ma, 2014, Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis, Mediators Inflamm, 2014, 10.1155/2014/179284 Hattori, 2019, Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis, Clin Rheumatol, 38, 181, 10.1007/s10067-017-3829-9 Tokai, 2018, Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis, PLoS ONE, 13, e0202601, 10.1371/journal.pone.0202601 Ma, 2015, Continuously elevated serum matrix metalloproteinase-3 for 3–6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study, Arthritis Res Ther, 17, 289, 10.1186/s13075-015-0803-2 Ally, 2013, Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis, Mediators Inflamm, 2013, 1, 10.1155/2013/183653